News

Centre imposes stricter regulation on Pregabalin sales

The ministry said violations and non-compliance would attract penal action under the Drugs and Cosmetics Act, 1940, and related rules

PTI

New Delhi: The Union Health Ministry has brought pregabalin, a drug used for treating chronic pain and certain neurological conditions, under the stricter Schedule H1 category amid reports of its misuse and abuse.

The ministry notified the inclusion of pregabalin under Schedule H1 of the Drugs Rules, 1945, through a gazette notification on May 20.

"The decision has been taken in view of reports received from certain states regarding the misuse and abuse of Pregabalin, particularly among youth," the ministry said.

The drug, which is prescribed for the treatment of chronic pain, neuropathies, fibromyalgia, and certain neurological conditions, has reportedly been misused for its sedative, euphoric, and dissociative effects.

The ministry cited seizures of illegal stocks and sales of pregabalin in parts of the country.

The medicine was earlier regulated under Schedule H under the Drugs and Cosmetics Rules, 1945.

Under the revised classification, the drug can now be sold only against a valid prescription issued by a registered medical practitioner (RMP).

Retailers will now have to maintain a separate register recording details of prescriptions and sales, while manufacturers must prominently display the prescribed 'Schedule H1 Drug Warning' label on product packaging, a ministry statement said.

The ministry said violations and non-compliance would attract penal action under the Drugs and Cosmetics Act, 1940, and related rules.

According to the statement, the move is aimed at "strengthening accountability across the supply chain, preventing unauthorised access, enhancing prescription monitoring, curbing illegal trafficking, and safeguarding public health from drug misuse and abuse."

This report was published from a syndicated wire feed. Apart from the headline, the EdexLive Desk has not edited the copy.

UGC NET December 2026 subject-wise exam schedule released; check dates for English, Commerce, Management and other subjects

KSET Result 2026 declared: 8,171 candidates qualify; KEA releases subject-wise cutoff marks

How Virat Kohli inspired Aaryavir Sehwag to reject labels and master adaptability for India Under-19

Young scientists urged to build startups as India targets $1 trillion bioeconomy by 2047

GSET Hall Ticket 2026 hall ticket link activated at gujaratset.ac.in; Exam on November 29